GB0325291D0 - Novel combination - Google Patents

Novel combination

Info

Publication number
GB0325291D0
GB0325291D0 GBGB0325291.3A GB0325291A GB0325291D0 GB 0325291 D0 GB0325291 D0 GB 0325291D0 GB 0325291 A GB0325291 A GB 0325291A GB 0325291 D0 GB0325291 D0 GB 0325291D0
Authority
GB
United Kingdom
Prior art keywords
novel combination
novel
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0325291.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GBGB0325291.3A priority Critical patent/GB0325291D0/en
Publication of GB0325291D0 publication Critical patent/GB0325291D0/en
Priority to PCT/IB2004/003444 priority patent/WO2005042022A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0325291.3A 2003-10-29 2003-10-29 Novel combination Ceased GB0325291D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0325291.3A GB0325291D0 (en) 2003-10-29 2003-10-29 Novel combination
PCT/IB2004/003444 WO2005042022A2 (fr) 2003-10-29 2004-10-20 Combinaison nouvelle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0325291.3A GB0325291D0 (en) 2003-10-29 2003-10-29 Novel combination

Publications (1)

Publication Number Publication Date
GB0325291D0 true GB0325291D0 (en) 2003-12-03

Family

ID=29725605

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0325291.3A Ceased GB0325291D0 (en) 2003-10-29 2003-10-29 Novel combination

Country Status (2)

Country Link
GB (1) GB0325291D0 (fr)
WO (1) WO2005042022A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005047946A1 (de) * 2005-10-06 2007-05-03 Bayer Healthcare Ag Verwendung von Aktivatoren der löslichen Guanylatzyklase zur Behandlung von akuten und chronischen Lungenkrankheiten
SI1891952T1 (sl) 2006-05-04 2012-02-29 Lek Pharmaceuticals, D.D. Farmacevtski sestavek, ki vsebuje olmesartan medoksomil
KR101628028B1 (ko) * 2006-06-27 2016-06-08 다이이찌 산쿄 가부시키가이샤 압축 제제
DE102006031175A1 (de) * 2006-07-06 2008-01-10 Bayer Healthcare Ag Wässrige Arzneimittelformulierung von 4-[((4-Carboxybutyl)-(2[(4-phenethyl-benzyl)oxy]-phenethyl)amino)methyl]benzoesäur
WO2018069148A1 (fr) * 2016-10-11 2018-04-19 Bayer Pharma Aktiengesellschaft Combinaison contenant des activateurs gcs et des antagonistes du récepteur des minéralocorticoïdes
JP7101688B2 (ja) 2016-10-11 2022-07-15 バイエル・ファルマ・アクティエンゲゼルシャフト ｓＧＣ刺激薬とミネラルコルチコイド受容体拮抗薬とを含む組み合わせ
CN110691612A (zh) * 2016-11-10 2020-01-14 阿瑞那制药公司 采用ralinepag与其他药剂的组合治疗pah的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
CZ302691B6 (cs) * 1998-07-08 2011-09-07 Sanofi - Aventis Deutschland GmbH N-Arylamidová sloucenina, zpusob její prípravy, farmaceutický prostredek tuto slouceninu obsahující, tato sloucenina pro použití jako aktivátor a pro použití k terapii nebo profylaxi
WO2000012110A2 (fr) * 1998-08-26 2000-03-09 Queen's University At Kingston Methodes de remodelisation des voies neuronales et cardiovasculaires
CA2678256A1 (fr) * 2000-10-27 2002-05-02 Nitromed Inc. Methodes de traitement de maladies vasculaires caracterisees par une insuffisance en monoxyde d'azote
WO2003090870A1 (fr) * 2002-04-26 2003-11-06 Altana Pharma Ag Nouvelle utilisation d'activateurs de la guanylate cyclase pour le traitement d'insuffisance respiratoire

Also Published As

Publication number Publication date
WO2005042022A2 (fr) 2005-05-12
WO2005042022A3 (fr) 2005-08-04

Similar Documents

Publication Publication Date Title
EP1615948A4 (fr) Amplification immunologique
DE502004011703D1 (en) N-heterocyclyl-phenylsubstituierte cyclische ketoenole
EP1635758A4 (fr) Dispositif de reeducation orthodynamique
DE602004012071D1 (en) T-hilfe
DE602004020356D1 (en) Phenoxyessigsäurederivate
DE602004030538D1 (en) Präzisionssubstratlagerbehälter
EP1629178A4 (fr) Boulon d'ancrage
DE502004009243D1 (en) Spirocyclische cyclohexan-derivate
DE602004027010D1 (en) Thermotherapiehülle
DE502004006683D1 (en) Injection-locked-oscillator-schaltkreis
DE502004003476D1 (en) Standfuss
DE502004011852D1 (en) Nspritzventil
ZA200603778B (en) Novel oxy-nitriles
DE502004004146D1 (en) Pyrazolverbindungen
DE112004002769D2 (en) Schienengeführtes transportsystem
DE60333037D1 (en) Laser-radar
DK1665437T3 (en) Reformeringsmodul
DE602004012262D1 (en) Benzimidazolonverbindung
DE502004011343D1 (en) Rotorspinnmaschine
IL175678A0 (en) Novel piperidine-substituted indoles-or heteroderivatives thereof
DE602004020525D1 (en) Imidazolderivate
DE502004012153D1 (en) Rotorspinnmaschine
GB0325291D0 (en) Novel combination
GB0318094D0 (en) Novel combination
DE10394343D2 (en) Berührungslose biometrische erkennung

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)